These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15614963)

  • 1. Warning on two specific 3-drug regimens: Viread + Didanosine + either Sustiva or Viramune.
    AIDS Treat News; 2004 Oct; (406):5. PubMed ID: 15614963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early virological failure with a combination of tenofovir, didanosine and efavirenz.
    Podzamczer D; Ferrer E; Gatell JM; Niubo J; Dalmau D; Leon A; Knobel H; Polo C; Iniguez D; Ruiz I
    Antivir Ther; 2005; 10(1):171-7. PubMed ID: 15751775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First of a kind in HIV treatment.
    FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early virological failure in treatment-naive HIV-infected adults receiving didanosine and tenofovir plus efavirenz or nevirapine.
    León A; Martinez E; Mallolas J; Laguno M; Blanco JL; Pumarola T; Gatell JM
    AIDS; 2005 Jan; 19(2):213-5. PubMed ID: 15668550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New once-daily HIV combination better tolerated.
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):826. PubMed ID: 15566325
    [No Abstract]   [Full Text] [Related]  

  • 6. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
    HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily dosing and the treatment of HIV disease.
    Laurence J
    AIDS Read; 2006 Sep; 16(9):444-5. PubMed ID: 17024761
    [No Abstract]   [Full Text] [Related]  

  • 8. A once-daily combination tablet (Atripla) for HIV.
    Med Lett Drugs Ther; 2006 Sep; 48(1244):78-9. PubMed ID: 17001298
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2010 Feb; 24(2):133-4. PubMed ID: 20156092
    [No Abstract]   [Full Text] [Related]  

  • 10. One pill, once daily: now an option for HIV patients.
    Sax PE
    AIDS Clin Care; 2006 Sep; 18(9):77. PubMed ID: 16995270
    [No Abstract]   [Full Text] [Related]  

  • 11. Switching drugs for lipodystophy.
    Fornataro K
    Body Posit; 1999 May; 12(5):13. PubMed ID: 11366306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir-related nephrotoxicity in HIV-infected patients.
    Barrios A; García-Benayas T; González-Lahoz J; Soriano V
    AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexpected drug interactions and adverse events with antiretroviral drugs.
    Moyle G; Boffito M
    Lancet; 2004 Jul 3-9; 364(9428):8-10. PubMed ID: 15234836
    [No Abstract]   [Full Text] [Related]  

  • 14. Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine?
    Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J
    J Acquir Immune Defic Syndr; 2004 Apr; 35(4):427-8. PubMed ID: 15097160
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple combinations regimens for HIV.
    Lancet Infect Dis; 2003 Nov; 3(11):682. PubMed ID: 14603888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 17. I want a new drug. An overview of three new anti-HIV drugs.
    Simmons P
    Res Initiat Treat Action; 1998 Jun; 4(3):9-11. PubMed ID: 11365539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaboration begins on combined drug.
    AIDS Patient Care STDS; 2005 Feb; 19(2):129. PubMed ID: 15747431
    [No Abstract]   [Full Text] [Related]  

  • 19. Should tenofovir ever be used in association with didanosine?
    Diaz RS
    Braz J Infect Dis; 2005 Dec; 9(6):452-3. PubMed ID: 16410938
    [No Abstract]   [Full Text] [Related]  

  • 20. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.